Allergy Immunotherapy Market By Type Of Allergy (Food Allergy, Allergic Rhinitis, Skin Allergy, Insect-Bite Allergy, Other Allergies), By Type Of Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT) ) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026
Industry Outlook
Allergy immunotherapy market accounted for a market value of US$ 1,499.0 Mn in 2017 and projected to grow at a CAGR of 10.1% during the forecast period from 2018 to 2026. Allergy immunotherapy helps to prevent or minimize the allergic reactions and provide log-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.
"Subcutaneous immunotherapy (SCIT) is highly demanded treatment for allergic rhinitis & asthma as it provides long-term relief to the patients"
SCIT is an effective therapy against allergic diseases as it delivers symptomatic relief by altering the effect of allergic reaction by focusing the basic mechanism of immunology. Thus, in 2017 SCIT identified as the largest allergy immunotherapy type that is preferred and adopted by most of the physicians. In addition to that, compared with conventional treatment the cost-effectiveness of SCIT is high and new molecules under trials will assist the overall growth of allergy immunotherapy.
"Air pollution has increased due to infrastructural development & industrialization in China & India specifically assisting the growth in asthma & allergic rhinitis"
The Asia Pacific is the fastest growing segment due to key driving factors such as rising prevalence & awareness related to allergic conditions, and industrialization & infrastructural development has increased air pollution in China & India. According to the World Health Organization (WHO), there has been significant growth in the prevalence of allergic rhinitis in Asia–Pacific within the last decade that has increased the economic burden. According to experts, the key factors responsible for sudden growth in allergic rhinitis is result of changing the environment, development in hygiene & reduced infections, and increasing cases of genetic complications.
Historical & Forecast Period
The allergy immunotherapy market analyzed considering current market trends for base year 2017 and based on future trends CAGRs calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
This report on allergy immunotherapy market covers exhaustive analysis with quantitative and qualitative data points associated with the major market dynamics (opportunities, drivers, & restraints) affecting or assisting the market along with regional trends and further sub-segmented market by countries. Extensive information on the global allergy immunotherapy market provided in the report by segmenting the market based on the type of allergy, treatment, and geography. The major objective of publishing this research report is to assist the companies operating in this market to design & implement strategies in the allergy immunotherapy market.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2017-2027 |
| Base Year | 2018 |
| Forecast Period | 2019-2027 |
| Historical Year | 2017 |
| Unit | USD Million |
| Segmentation |
Allergy Type Segment (2016–2026; US$ Mn) |
|
Treatment Segment (2016–2026; US$ Mn) |
|
|
Geography Segment (2016–2026; US$ Mn) |
This report also covers segments including data specific to major market trends, opportunities, drivers, and restraints, to gain precise information against global allergy immunotherapy market. The key market players analyzed in the report based on major attributes such as business strength, product portfolio, and important market strategies. The report also covers an attractive investment proposition based on the in-depth geographical research executed based on PESTEL analysis. The companies profiled in the report are Hollister Stier, Leti, WOLW Pharma, Aimmune Therapeutics, ALK-Abello A/S, Stallergenes Greer, Allergopharma, DBV Technologies, Allergy Therapeutics, Biomay AG, HAL Allergy Group, Circassia, and Merck KGaA, among others.
Key questions answered in this report
- Which is the trending allergy type in the market & Why?
- What are the recent market strategies adopted and implemented by key companies present in allergy immunotherapy market?
- Which are the most attractive markets (regions and countries) prominent and rapidly growing throughout the forecast period in allergy immunotherapy market?
- Which is the largest and fastest growing allergy immunotherapy treatments globally?
- Which are the major treatments contributing to the overall growth of allergy immunotherapy in the near future?
- How is the competitive environment in allergy immunotherapy market and strategies of major companies in this industry?
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global AI Market Portraiture
2.2. Global AI Market, by Type of Allergy, 2017 (US$ Mn)
2.3. Global AI Market, by Type of Treatment, 2017 (US$ Mn)
2.4. Global AI Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global Allergy Immunotherapy (AI) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Allergy Immunotherapy (AI) Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Food Allergy
4.3. Allergic Rhinitis
4.4. Skin Allergy
4.5. Insect-bite Allergy
4.6. Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)
Chapter 5. Global Allergy Immunotherapy (AI) Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Subcutaneous Immunotherapy (SCIT)
5.3. Sublingual Immunotherapy (SLIT)
Chapter 6. Global Allergy Immunotherapy (AI) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America AI Market Analysis, 2016 – 2026
6.2.1. North America AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.2.2. North America AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.2.3. North America AI Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe AI Market Analysis, 2016 – 2026
6.3.1. Europe AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.3.2. Europe AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.3.3. Europe AI Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific AI Market Analysis, 2016 – 2026
6.4.1. Asia Pacific AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific AI Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America AI Market Analysis, 2016 – 2026
6.5.1. Latin America AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.5.2. Latin America AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.5.3. Latin America AI Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) AI Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.6.3. MEA AI Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. ALK-Abello A/S
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. HAL Allergy Group
7.3. Circassia
7.4. Aimmune Therapeutics
7.5. Merck KGaA
7.6. Anergis
7.7. Biomay AG
7.8. Stallergenes Greer
7.9. DBV Technologies
7.10. Allergy Therapeutics
* AI - Allergy Immunotherapy
TABLE 1 : Global Allergy Immunotherapy (AI) Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 2 : Global AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 3 : North America AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 4 : North America AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 5 : North America AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 : Europe AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 7 : Europe AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 8 : Europe AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 : Asia Pacific AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 10 : Asia Pacific AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 11 : Asia Pacific AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Latin America AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 13 : Latin America AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 14 : Latin America AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 : Middle East & Africa AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 16 : Middle East & Africa AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 17 : Middle East And Africa AI Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 : ALK-Abello A/S: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 : Stallergenes Greer: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 : DBV Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 : Allergy Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 : HAL Allergy Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 : Circassia: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 : Aimmune Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 : Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 : Anergis: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 : Biomay AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 : Allergy Immunotherapy (AI): Market Segmentation
FIG. 2 : Global AI Market Share, by Type of Allergy, 2017 (US$ Mn)
FIG. 3 : Global AI Market Share, by Type of Treatment, 2017 (US$ Mn)
FIG. 4 : Global AI Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 : Attractive Investment Proposition, by Geography, 2017
FIG. 6 : Market Competition Landscape, by Key Players, 2017
FIG. 7 : Global Food AI Market, 2016 – 2026 (US$ Mn)
FIG. 8 : Global Allergic Rhinitis Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Skin AI Market, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Insect-bite AI Market, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Other Allergies Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Subcutaneous Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Sublingual Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. AI Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada AI Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. AI Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany AI Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest Of Europe AI Market, 2016 – 2026 (US$ Mn)
FIG. 19 : Japan AI Market, 2016 – 2026 (US$ Mn)
FIG. 20 : China AI Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest Of Asia Pacific AI Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil AI Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico AI Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest Of Latin America AI Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC AI Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest Of Middle East And Africa AI Market, 2016 – 2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)